Novartis Aktie
107,00
EUR
-3,95
EUR
-3,56
%
98,87
CHF
-4,29
CHF
-4,16
%
Werbung
Novartis Aktie Analyse
| 19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Hold | Deutsche Bank AG | |
| 25.04.17 | Novartis Hold | S&P Capital IQ | |
| 21.04.17 | Novartis Neutral | UBS AG | |
| 18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.17 | Novartis Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 06.04.17 | Novartis Neutral | UBS AG | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.17 | Novartis Hold | Deutsche Bank AG | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 10.03.17 | Novartis Hold | Deutsche Bank AG | |
| 06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | UBS AG | |
| 26.01.17 | Novartis Hold | Deutsche Bank AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.17 | Novartis Hold | Deutsche Bank AG | |
| 03.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis Hold | Deutsche Bank AG | |
| 08.12.16 | Novartis Neutral | UBS AG | |
| 30.11.16 | Novartis Hold | Deutsche Bank AG | |
| 26.10.16 | Novartis Hold | Deutsche Bank AG | |
| 25.10.16 | Novartis Hold | S&P Capital IQ | |
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.09.16 | Novartis Neutral | BNP PARIBAS | |
| 04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 20.07.16 | Novartis Neutral | UBS AG | |
| 20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.16 | Novartis Halten | Independent Research GmbH | |
| 06.07.16 | Novartis Halten | Independent Research GmbH | |
| 23.06.16 | Novartis Hold | Deutsche Bank AG | |
| 23.05.16 | Novartis Neutral | Citigroup Corp. | |
| 19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.05.16 | Novartis Neutral | Citigroup Corp. | |
| 09.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 28.04.16 | Novartis Neutral | UBS AG | |
Werbung
Werbung